Evaluation of S100A12 and Apo-A1 plasma level potency in untreated new relapsing–remitting multiple sclerosis patients and their family members

Multiple sclerosis is an inflammatory disease of the spinal cord and brain. Receptor for advanced glycation end products and Apolipoprotein A1 (Apo-AI) have been recommended to have a pathogenic role in the neuroinflammatory disorder as multiple sclerosis. The purpose of this research was to measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Samangooei, Mahsa, Farjam, Mojtaba, Etemadifar, Masoud, Taheri, Atefeh, Meshkibaf, Mohammad Hassan, Movahedi, Bahram, Niknam, Zahra, Noroozi, Saam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828754/
https://www.ncbi.nlm.nih.gov/pubmed/35140322
http://dx.doi.org/10.1038/s41598-022-06322-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828754/
https://www.ncbi.nlm.nih.gov/pubmed/35140322
http://dx.doi.org/10.1038/s41598-022-06322-4

Ejemplares similares